2008Journal of interventional radiologyRequires access

Bronchial arterial infusion versus bronchial combined pulmonary arterial infusion for pulmonary metastatic tumors

Xiao Xiang-shen

Open publisher page 0 citations

Abstract

Objective To evaluate the pulmonary metastatic tumor response to different ways of transcatheter arterial infusion.Methods Thirty-five patients with pulmonary metastatic tumors were randomized divided into two groups:15 patients with 49 lesions treated with bronchial arterial infusion(BAI) and 20 patients with 65 lesions treated with bronchial arterial infusion(BAI)combined with pulmonary arterial infusion(PAI).The therapeutic reponse was assessed by the WHO evaluation criteria.Results The total effective rate(CR + PR) of BAI was 65.3%(32/49),PAI + BAI was 61.5%(40/65) showing no statistical difference.The median survival time of BAI was 9 mo,BAI + PAI was 11.5 mo,demonstrating no statistical significance.Conclusions BAI should be the primary treatment for pulmonary metastatic tumor.

About this research paper

What this paper is about

Objective To evaluate the pulmonary metastatic tumor response to different ways of transcatheter arterial infusion.Methods Thirty-five patients with pulmonary metastatic tumors were randomized divided into two groups:15 patients with 49 lesions treated with bronchial arterial infusion(BAI) and 20 patients with 65 lesions treated with bronchial arterial infusion(BAI)combined with pulmonary arterial infusion(PAI).The therapeutic reponse was assessed by the WHO evaluation criteria.Results The total effective rate(CR + PR) of BAI was 65.3%(32/49),PAI + BAI was 61.5%(40/65) showing no statistical difference.The median survival time of BAI was 9 mo,BAI + PAI was 11.5 mo,demonstrating no statistical significance.Conclusions BAI should be the primary treatment for pulmonary metastatic tumor.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the pulmonary metastatic tumor response to different ways of transcatheter arterial infusion.Methods Thirty-five patients with pulmonary metastatic tumors were randomized divided into two groups:15 patients with 49 lesions treated with bronchial arterial infusion(BAI) and 20 patients with 65 lesions treated with bronchial arterial infusion(BAI)combined with pulmonary arterial infusion(PAI).The therapeutic reponse was assessed by the WHO evaluation criteria.Results The total effective rate(CR + PR) of BAI was 65.3%(32/49),PAI + BAI was 61.5%(40/65) showing no statistical difference.The median survival time of BAI was 9 mo,BAI + PAI was 11.5 mo,demonstrating no statistical significance.Conclusions BAI should be the primary treatment for pulmonary metastatic tumor.

Key concepts: Medicine, Arterial blood, Statistical significance, Arterial blood gas analysis, Pulmonary arterial pressure, Bronchial artery, Lung, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Bronchial arterial infusion versus bronchial combined pulmonary arterial infusion for pulmonary metastatic tumors — Research Paper | ScholarLens